Suramin is a Potent Inhibitor of Vascular Endothelial Growth Factor. A Contribution to the Molecular Basis of its Antiangiogenic Action

Author： Waltenberger J.   Mayr U.   Frank H.   Hombach V.  

Publisher： Academic Press

ISSN： 0022-2828

Source： Journal of Molecular and Cellular Cardiology, Vol.28, Iss.7, 1996-07, pp. : 1523-1529

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular endothelial growth factor and its soluble receptor in ovarian pathology

By Artini PG   Cristello F   Monti M   Cela V   Battaglia C   D'Ambrogio G   Genazzani AR  

Gynecological Endocrinology, Vol. 21, Iss. 1, 2005-07 ,pp. : 50-56

Informa Healthcare

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Inhibitor Therapy and Cardiovascular and Renal Damage in Renal Cell Carcinoma

By  

Current Vascular Pharmacology, Vol. 16, Iss. 2, 2018-01 ,pp. : 190-196

Bentham Science Publishers

Access to resources Recommend Favorite

Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation

By Bausero P.  

Angiogenesis, Vol. 2, Iss. 2, 1998-01 ,pp. : 167-182

Springer Publishing Company

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Increases Release of Gelatinase A and Decreases Release of Tissue Inhibitor of Metalloproteinases by Microvascular Endothelial Cells in Vitro

By Lamoreaux W.J.   Fitzgerald M.E.C.   Reiner A.   Hasty K.A.   Charles S.T.  

Microvascular Research, Vol. 55, Iss. 1, 1998-01 ,pp. : 29-42

Academic Press

Access to resources Recommend Favorite

Vascular endothelial growth factor and corpus luteum angiogenesis

By Charnock-Jones D.S.   Smith S.K.  

Angiogenesis, Vol. 2, Iss. 2, 1998-01 ,pp. : 119-121

Springer Publishing Company

Access to resources Recommend Favorite